Apogee Therapeutics, Inc. · NASDAQ:APGE

Henderson Michael Thomas sold 80,000 Apogee Therapeutics, Inc. shares (Form 4)

Traded Jun 22, 2026 · Filed Jun 24, 2026

On Jun 22, 2026, Henderson Michael Thomas (Director, Chief Executive Officer) sold 80,000 Apogee Therapeutics, Inc. shares at US$132.54 for US$10.6M under a trading plan, leaving 1,015,987 shares. Filed Jun 24, 2026 (Form 4).

Sold
80,000 shares
Price
US$132.54
Value
US$10.6M
Holding after
1,015,987 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockSale80,000US$132.541,015,987Direct

Source

View original at SEC

Related